متابعة
Lisa H. Butterfield
Lisa H. Butterfield
Merck Research Laboratories
بريد إلكتروني تم التحقق منه على merck.com
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
B cells and tertiary lymphoid structures promote immunotherapy response‏
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...‏
Nature 577 (7791), 549-555, 2020‏
21102020
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial‏
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...‏
The Lancet Oncology 18 (11), 1493-1501, 2017‏
12982017
Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic …‏
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...‏
Journal of clinical oncology 29 (3), 330-336, 2011‏
7022011
Immunotherapy of cancer in 2012‏
JM Kirkwood, LH Butterfield, AA Tarhini, H Zarour, P Kalinski, S Ferrone‏
CA: a cancer journal for clinicians 62 (5), 309-335, 2012‏
6072012
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides‏
LH Butterfield, A Ribas, VB Dissette, Y Lee, JQ Yang, P De la Rocha, ...‏
Clinical Cancer Research 12 (9), 2817-2825, 2006‏
6032006
T-cell responses to HLA-A* 0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer‏
LH Butterfield, A Ribas, WS Meng, VB Dissette, S Amarnani, HT Vu, ...‏
Clinical Cancer Research 9 (16), 5902-5908, 2003‏
4712003
Current developments in cancer vaccines and cellular immunotherapy‏
A Ribas, LH Butterfield, JA Glaspy, JS Economou‏
Journal of clinical oncology 21 (12), 2415-2432, 2003‏
4202003
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial‏
FS Hodi, S Lee, DF McDermott, UN Rao, LH Butterfield, AA Tarhini, ...‏
Jama 312 (17), 1744-1753, 2014‏
4162014
A comparison of gene transfer methods in human dendritic cells.‏
JF Arthur, LH Butterfield, MD Roth, LA Bui, SM Kiertscher, R Lau, ...‏
Cancer Gene Therapy 4 (1), 17-25, 1997‏
4151997
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma‏
AA Tarhini, H Zahoor, Y Lin, U Malhotra, C Sander, LH Butterfield, ...‏
Journal for immunotherapy of cancer 3, 1-6, 2015‏
3882015
Dendritic cell–based cancer vaccines‏
PM Santos, LH Butterfield‏
The Journal of Immunology 200 (2), 443-449, 2018‏
3802018
Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade‏
J Zhou, KM Mahoney, A Giobbie-Hurder, F Zhao, S Lee, X Liao, S Rodig, ...‏
Cancer immunology research 5 (6), 480-492, 2017‏
3602017
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab‏
AA Tarhini, H Edington, LH Butterfield, Y Lin, Y Shuai, H Tawbi, C Sander, ...‏
PloS one 9 (2), e87705, 2014‏
3362014
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma‏
LH Butterfield, A Ribas, VB Dissette, SN Amarnani, HT Vu, D Oseguera, ...‏
Clinical Cancer Research 9 (3), 998-1008, 2003‏
3322003
Cancer vaccines‏
LH Butterfield‏
Bmj 350, 2015‏
3242015
Novel technologies and emerging biomarkers for personalized cancer immunotherapy‏
J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ...‏
Journal for immunotherapy of cancer 4, 1-25, 2016‏
2922016
Next generation of immunotherapy for melanoma‏
JM Kirkwood, AA Tarhini, MC Panelli, SJ Moschos, HM Zarour, ...‏
Journal of Clinical Oncology 26 (20), 3445-3455, 2008‏
2892008
Generation of human T-cell responses to an HLA-A2. 1-restricted peptide epitope derived from α-fetoprotein‏
LH Butterfield, A Koh, W Meng, CM Vollmer, A Ribas, V Dissette, E Lee, ...‏
Cancer research 59 (13), 3134-3142, 1999‏
2601999
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy‏
S Gnjatic, V Bronte, LR Brunet, MO Butler, ML Disis, J Galon, ...‏
Journal for immunotherapy of cancer 5, 1-18, 2017‏
2482017
α-Fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma‏
CM Vollmer Jr, FC Eilber, LH Butterfield, A Ribas, VB Dissette, A Koh, ...‏
Cancer Research 59 (13), 3064-3067, 1999‏
2391999
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20